7Baggers
Quarterly
Annual
    Unit: USD2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 
      
    		                     
      operating activities
    		                     
      net income
    		-21,156,000 -21,002,000 -18,875,000 -18,477,000 -15,700,000 -14,420,000 -17,618,000 -25,387,000 -43,786,000 -13,161,000 -15,673,000 -16,513,000 -14,380,000 -18,253,000 -10,057,000 -18,054,000 -6,836,000 -6,043,000 -9,253,000 -6,815,000 -8,619,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                     
      stock-based compensation
    		3,786,000 4,466,000 4,233,000 4,335,000 4,132,000 3,943,000 4,677,000 4,795,000 4,679,000 3,687,000 4,258,000 4,051,000 4,206,000 692,000 925,000 778,000 674,000 501,000 172,000 411,000 568,000 
      depreciation and amortization
    		3,494,000 4,277,000 4,451,000 4,684,000 4,994,000 4,754,000 4,575,000 3,435,000 1,536,000 1,474,000 1,442,000 1,556,000 1,200,000 1,223,000 1,149,000 1,151,000 1,476,000 1,629,000 1,649,000 1,807,000 1,628,000 
      amortization of marketable securities discount
    		                     
      other noncash expense
    		571,000 620,000 656,000 253,000 304,000 117,000 234,000               
      changes in operating assets and liabilities, net of effects of acquisition:
    		                     
      accounts receivable
    		1,076,000 206,000 135,000 -381,000 -1,231,000 -156,000 -379,000 -124,000 -164,000 -20,000 810,000 -271,000 334,000 -755,000 435,000 -157,000 376,000 -594,000 983,000 -757,000 -212,000 
      inventories
    		-1,785,000 298,000 -55,000 -467,000 1,000 -514,000 1,650,000 -1,666,000 -440,000 86,000 16,000 -409,000 -125,000 236,000 39,000 295,000 -71,000 201,000 520,000 -239,000 367,000 
      prepaid expenses and other current assets, deposits and other assets
    		-4,809,000 -2,644,000 -3,297,000 -24,804,000 12,219,000 -183,000 -12,852,000 -2,448,000 -6,617,000 489,000 -2,317,000 1,330,000 -1,321,000 1,131,000 -4,273,000 1,395,000 -777,000 331,000 -167,000 -1,801,000 590,000 
      accounts payable, accrued expenses and non-current liabilities
    		7,803,000 2,337,000 -3,326,000 2,266,000 3,532,000 -3,486,000 381,000               
      net cash from operating activities
    		-11,020,000 -11,442,000 -16,078,000 -32,591,000 8,251,000 -9,933,000 -19,446,000 -15,843,000 -19,656,000 -4,654,000 -12,460,000 -14,843,000 -9,225,000 -12,303,000 -7,165,000 -4,757,000 -3,776,000 -3,817,000 -6,988,000 -6,041,000 -5,145,000 
      investing activities
    		                     
      acquisitions of property, plant and equipment
    		-9,751,000 -9,196,000 -17,512,000 6,958,000 -32,275,000 -17,704,000 -11,434,000 -7,240,000 -22,370,000 -14,947,000 -31,218,000 -28,707,000 -16,788,000 -9,537,000 -4,630,000 -4,149,000 -136,000 -843,000 -777,000 -210,000 -1,223,000 
      proceeds from sale of investment tax credit
    		                     
      payment of earnest money deposit
    		                     
      acquisition of cultivateai
    		                     
      proceeds from maturity of marketable securities
    		   0 0                 
      proceeds from sale of property, plant and equipment
    		      67,000             13,000  
      net cash from investing activities
    		-10,485,000 -9,196,000 -17,512,000 6,958,000 -32,353,000 15,341,000 124,183,000 48,524,000 53,220,000 -16,211,000 7,861,000 16,365,000 8,544,000 -431,899,000 -4,630,000 -4,149,000 -136,000 -843,000 -777,000 -197,000 -2,704,000 
      financing activities
    		                     
      proceeds from issuance of remarketed bonds
    		0                     
      extinguishment of 2021 bonds
    		0                     
      payment of debt offering costs
    		0                     
      proceeds from the exercise of warrants
    		                     
      payment of loans payable
    		-24,000 -33,000 -32,000 -39,000 -48,000                 
      payment of finance lease liabilities
    		-323,000 -232,000 -23,000 0 0 1,000 -23,000 4,304,000 -4,229,000 -53,000 -34,000 -1,492,000          
      repurchases of common stock
    		                     
      net cash from financing activities
    		-944,000   -39,000 -48,000 -40,000 -62,000 4,265,000 -4,268,000 138,919,000 -354,000 -1,662,000 -8,340,000 64,073,000 458,780,000 6,623,000 78,196,000 1,708,000 752,000 1,596,000 -362,000 
      net increase in cash and cash equivalents
    		-22,449,000 -25,235,000 -35,042,000 -25,672,000 -24,150,000 5,368,000 104,675,000 36,946,000 29,296,000 118,054,000 -4,953,000    446,985,000 -2,283,000 74,284,000 -2,952,000 -7,013,000 -4,642,000 -8,211,000 
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 375,597,000 0 0 0 315,376,000 0 0 0 136,033,000           
      cash, cash equivalents and restricted cash at end of period
    		-22,449,000 -25,235,000 340,555,000 -25,672,000 -24,150,000 5,368,000 420,051,000 36,946,000 29,296,000 118,054,000 131,080,000           
      changes in operating assets and liabilities:
    		                     
      net cash from by financing activities
    		  -1,452,000                   
      impairment loss
    		       0              
      loss on disposal of assets
    		           0 183,000         
      amortization of marketable securities (discount) premium
    		   0 0 12,000 -114,000               
      acquisition of patent portfolio
    		       0 0 0 -10,000           
      purchase of marketable securities
    		       0 855,000 -99,264,000 -31,993,000 0 0         
      debt and equity offering costs
    		       0 0   -36,000 -162,000 -3,074,000 -31,683,000 -200,000 -6,055,000 -63,000 -52,000 -54,000 -161,000 
      proceeds from issuance of common stock and common stock warrants
    		       0 0   1,824,000 0 -1,824,000 489,373,000 6,429,000      
      proceeds from exercise of warrants
    		       0 0 0 3,000  0 2,000 1,117,000       
      net settlement of common stock under stock plans
    		       -1,000 1,000 -66,000 -220,000 -1,904,000    -19,000 -21,000   0  
      proceeds from property, plant and equipment
    		                     
      proceeds from sale and maturity of marketable securities
    		      135,550,000 55,764,000 74,735,000 98,000,000 71,082,000           
      payment of debt
    		      -39,000               
      (gain) on forgiveness of sba loans
    		           0          
      amortization of marketable securities premium
    		       -32,000              
      other noncash income
    		       1,030,000 -505,000             
      accounts payable, accrued expenses and long-term liabilities
    		       4,055,000 774,000 1,091,000 -2,285,000    4,545,000 -906,000 857,000   1,039,000 293,000 
      purchase of patents and license
    		                     
      proceeds from issuance of 2021 bonds
    		           0 0         
      payment of loans payable - other
    		       -38,000 -40,000 31,000 -103,000  -45,000 -26,000 -27,000  -89,000 -238,000 -154,000   
      noncash interest expense
    		                     
      non-cash lease expense
    		          139,000 45,000 65,000 -75,000 17,000 17,000 16,000 14,000 15,000   
      non-cash interest expense
    		          1,150,000 -28,000 63,000 0 2,000 155,000 213,000 243,000 150,000 257,000 257,000 
      gain from the change in fair value of 2020/21 notes and 2020 notes embedded derivative liability
    		                     
      loss on conversion of 2020/21 notes to common stock
    		               1,373,000      
      acquisition of patents
    		                     
      proceeds from sale of marketable securities
    		           45,242,000          
      investment in juhl
    		                   0  
      payment on loans payable - other
    		                     
      proceeds from sba loans
    		                0     
      net increase in cash and cash equivalents and restricted cash
    		                     
      cash, cash equivalents and restricted cash
    		                     
      beginning of year
    		                     
      end of year
    		                     
      gain from change in fair value of derivative warrant liability
    		            -6,000 -43,000 53,000       
      gain from change in fair value of 2020/21 notes and 2020 notes embedded derivative liability
    		                     
      other non-cash expenses
    		            0         
      accounts payable, accrued expenses and long-term liabilities
    		            556,000         
      net increase (decrease) in cash and cash equivalents
    		            -9,021,000         
      cash, cash equivalents and restricted cash
    		                     
      beginning of period
    		            0 0 78,338,000  0 0 16,302,000  0 
      end of period
    		            -9,021,000 -380,129,000 525,323,000  74,284,000 -2,952,000 9,289,000  -8,211,000 
      loss from change in fair value of 2020/21 notes embedded derivative liability
    		                     
      (gain) on forgiveness of sba ppp loans
    		                     
      proceeds from sba ppp loans
    		                     
      income from change in fair value of 2020/21 notes embedded derivative liability
    		                     
      cash and cash equivalents
    		                     
      gain from the change in fair value of derivative warrant liability
    		                     
      gain from the change in fair value of 2020/21 notes and 2020 notes embedded derivative
    		                     
      loss on sale of property, plant and equipment
    		                     
      payment on secured debt
    		                     
      proceeds from sba loan
    		                     
      (gain) from change in fair value of derivative warrant liability
    		                0 -1,000 -7,000   
      gain from change in fair value of 2020/21 notes and 2020 notes embedded derivative liability
    		                -247,000     
      gain on retirement of property, plant and equipment
    		                     
      other non-cash expense
    		                    0 
      loss on retirement of property, plant and equipment
    		                     
      proceeds from issuance of common stock
    		                 1,313,000 958,000  0 
      (gain) from change in fair value of 2020/21 notes and 2020 notes embedded derivative liability
    		                  100,000   
      accounts payable, accrued expenses, and long-term liabilities
    		                  -1,150,000   
      (gain) income from the change in fair value of derivative warrant liability
    		                     
      (gain) from the change in fair value of the embedded derivative to the 2020 notes
    		                     
      loss on exchange or conversion of debt
    		                     
      payments on secured debt
    		                     
      (gain) income from change in fair value of derivative warrant liability
    		                    2,000 
      (gain) from change in fair value of 2020 notes embedded derivative
    		                    0 
      (gain) on sale of property, plant and equipment
    		                     
      loss on exchange of debt
    		                     
      proceeds from exercise of common stock warrants
    		                     
      cash, cash equivalent and restricted cash
    		                     
      loss/(gain) from the change in fair value of derivative warrant liability
    		                     
      income from the change in fair value of 2017 notes
    		                     
      loss on extinguishment of warrant liability
    		                     
      loss on issuance of equity
    		                     
      prepaid expenses and other current assets
    		                     
      proceeds from sales tax refund for property, plant and equipment
    		                     
      cash, cash equivalents, and restricted cash
    		                     
      ending of year
    		                     
      (gain) from the change in fair value of derivative warrant liability
    		                     
      loss/(gain) on exchange or conversion of debt
    		                     
      loss/(gain) on extinguishment of warrant liability
    		                     
      proceeds from issuance of common stock upon exercise of stock options and employee stock purchase plan
    		                     
      release of restricted cash held as collateral on 2017 notes
    		                     
      (gain) from the change in fair value of the embedded derivative to the 2022 notes
    		                     
      loss/(gain) from the change in fair value of 2017 notes
    		                     
      restricted certificate of deposit
    		                     
      proceeds from issuance of convertible debt
    		                     
      gain from change in fair value of embedded derivative of the 2022 notes
    		                     
      gain from change in fair value of 2017 notes
    		                     
      (gain) loss on extinguishment of debt
    		                     
      gain on extinguishment of warrant liability
    		                     
      income from change in fair value of derivatives
    		                     
      other
    		                     
      deposit on secured debt and other
    		                     
      non-cash stock-based compensation
    		                     
      loss on conversion of debt
    		                     
      gain from change in fair value of derivatives
    		                     
      deposits and other assets
    		                     
      restricted deposits
    		                     
      proceeds from sales tax refund
    		                     
      proceeds from issuance of 2017 notes
    		                     
      proceeds from issuance of secured debt
    		                     
      net (decrease) in cash and cash equivalents
    		                     
      income from change in fair value of warrant liabilities
    		                     
      gain from change in fair value of embedded derivative
    		                     
      changes in operating assets and liabilities
    		                     
      acquisition of agri-energy, net of cash assumed
    		                     
      proceeds from issuance of common stock and common stock units
    		                     
      proceeds from issuance of common stock upon exercise of stock options and espp
    		                     
      proceeds from issuance of convertible preferred stock
    		                     
      proceeds from issuance of convertible promissory notes with warrants
    		                     
      (gain) income from change in fair value of derivatives
    		                     
      cash flows from operating activities:
    		                     
      stock expense for shares issued pursuant to license agreements
    		                     
      non-cash interest expense and amortization of debt discounts and debt issue costs to non-cash interest expense
    		                     
      gain from change in derivative
    		                     
      loss on abandonment or disposal of fixed assets
    		                     
      margin deposit
    		                     
      cash flows from investing activities:
    		                     
      acquisition of agri-energy, net of cash acquired
    		                     
      proceeds from the sale of property and equipment
    		                     
      cash flows from financing activities:
    		                     
      proceeds from issuance of common stock pursuant to employee stock purchase plan
    		                     
      proceeds from issuance of convertible promissory notes with warrant
    		                     
      proceeds from issuance of secured long-term debt
    		                     
      proceeds from issuance of warrants
    		                     
      payments on secured long-term debt
    		                     
      deposit on secured long-term debt
    		                     
      proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commissions
    		                     
      deferred offering costs
    		                     
      debt issue costs
    		                     
      payment of stock issuance costs
    		                     
      cash and cash equivalents:
    		                     
      ending of period
    		                     
      supplemental disclosures of non-cash transactions—investing and financing:
    		                     
      conversion of preferred stock warrants to common stock warrants upon initial public offering and reclassification of related liability to additional paid-in capital
    		                     
      warrants issued with secured long-term debt
    		                     
      warrants issued with convertible promissory notes
    		                     
      noncash interest expense and amortization of debt discounts and debt issue costs to noncash interest expense
    		                     
      payment of principal and final payment on secured long-term debt
    		                     
      supplemental disclosures of noncash transactions—investing and financing:
    		                     
      promissory notes and accrued interest converted to series c preferred stock
    		                     
      issuance of common stock pursuant to license agreements
    		                     
      issuance of series c preferred stock upon exercise of warrant
    		                     
      issuance of series d-1 preferred stock to icm, inc. in exchange for a credit against future services
    		                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.